The reviewed preclinical studies identified several ILs linked to breast cancer metastases to bone, i.e., IL-1β, IL-2, IL-6, IL-8, IL-10, IL-11, IL-15, IL-17, IL-18, and IL-20. This evidence concerns the gene IL20 and breast carcinoma.